Showing 7981-7990 of 10617 results for "".
- Analysis of Dermatology Mobile Apps with AI Capability Reveals Weaknesses, Transparency Concernshttps://reachmd.com/news/analysis-of-dermatology-mobile-apps-reveals-weaknesses-transparency-concerns/2462434/A new analysis of dermatology mobile applications (apps) revealed transparency, validation, and accuracy concerns. "With advancements in mobile technology and artificial intelligence (AI) methods, there has been a substantial surge in the availability of direct-to-consumer mobile applicat
- Mathematicians Use AI to Identify Emerging COVID-19 Variantshttps://reachmd.com/news/mathematicians-use-ai-to-identify-emerging-covid-19-variants/2462277/Like many other RNA viruses, COVID-19 has a high mutation rate and short time between generations meaning it evolves extremely rapidly. This means identifying new strains that are likely to be problematic in the future requires consider
- European Partnership to Combat Type 1 Diabetes Receives €23 Million IHI Fundinghttps://reachmd.com/news/european-partnership-to-combat-type-1-diabetes-receives-23-million-ihi-funding/2462279/The T1D ChallengeType 1 Diabetes (T1D) is a growing concern, particularly among children and young people, leading to lifelong implications. Recent years, including during the COVID-19 pandemic, have witnessed an increase in T1D cases. T1D profoundly impacts th
- Clinical Trial Marks New Chapter for Gene Therapyhttps://reachmd.com/news/clinical-trial-marks-new-chapter-for-gene-therapy/2457472/First to use “spreading vector” technique In the quest to cure inherited retinal diseases, Casey Eye Institute is using a novel gene therapy viral vector and surgical approach. The setting? A clinic
- How Fusion Proteins Hijack Gene Regulators to Spur Childhood Cancerhttps://reachmd.com/news/how-fusion-proteins-hijack-gene-regulators-to-spur-childhood-cancer/2457473/BUFFALO, N.Y., — Many childhood cancers start with a hijacking at the molecular level. A group of abnormal proteins known as fusion proteins aberrantly engage with a collection of proteins that switches genes on and off. As a result, genes that should be activated get repressed a
- Audit of Food Donations Prompts Call for New Nutrition and Safety Standardshttps://reachmd.com/news/audit-of-food-donations-prompts-call-for-new-nutrition-and-safety-standards/2457457/New Curtin University research that analysed a whopping 85,000 kilograms of food donated to Foodbank WA over five days has prompted calls for an overhaul of laws and policies to ensure safe and nutritious food is available for its vulnerable clients. Lead author
- Weight Loss and Diabetes Management Drug Linked to Increased Residual Gastric Content Before Anesthesiahttps://reachmd.com/news/weight-loss-and-diabetes-management-drug-linked-to-increased-residual-gastric-content-before-anesthesia/2457446/UTHealth Houston research team for Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia: from left, Caroline Praestholm, MS; Sudipta Sen, MD; Omonel
- UGR Researchers Show That Just 5 Months of Exercise Can Reduce Fat and Cardiovascular Risk in Obese Childrenhttps://reachmd.com/news/ugr-researchers-show-that-just-5-months-of-exercise-can-reduce-fat-and-cardiovascular-risk-in-obese-children/2457447/A study led by researchers from the UGR's Department of Physical Education and Sports, in collaboration with paediatricians from the Paediatric Endocrinology Unit of the "Virgen de las Nieves" University Hospital in Granada and external national and international partners, has shown tha
- After Positive Phase 1 Results, Apogee to Test Twice-Yearly Dosing of Atopic Dermatitis Drug Candidatehttps://reachmd.com/news/after-positive-phase-1-results-apogee-to-test-twice-yearly-dosing-of-atopic-dermatitis-drug-candidate/2462261/Apogee Therapeutics announced positive interim phase 1 data from its first-in-human study of APG777, one of its lead product candidates being developed as a frontline treatment for moderate-to-severe atopic dermatitis (AD) and other inflammatory diseases. Pharmacokinetic (PK) data showed a half-l
- Study Shows New Class of Antivirals That Works Against SARS-CoV-2https://reachmd.com/news/study-shows-new-class-of-antivirals-that-works-against-sars-cov-2/2457436/EDMONTON — A University of Alberta research team has uncovered a new class of drugs with the potential to prevent or treat infections in a future viral outbreak. In the paper,